Beyond solid tumors, MR1 expression is also observed in multiple myeloma cell lines, which can present the vitamin-B derivative ligand to MAIT cells, which in turn can induce cytotoxic activity towards these myeloma cells (62). The gene discussed is MR1; the disease is plasma cell myeloma.